MKI67 and cervical cancer: Based on the findings of Ki67 staining, in comparison with the control group, TCS treatment resulted in a significant decline in the number of Ki67-positive cell in HeLa (Figure 2a) & caski cells (Figure 2b), indicating that TCS treatment had a proliferation inhibitory effect on cervical cancer cells.